Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Balimane

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biopharmaceutics & Drug Disposition|May 30, 1998
Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in ratsP J Sinko, P V Balimane
Journal of Pharmacological and Toxicological Methods|March 29, 2001
Current methodologies used for evaluation of intestinal permeability and absorptionP V Balimane, S Chong, R A Morrison
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell lineA Guo, P Hu, P V Balimane, et al.
Biochemical and Biophysical Research Communications|October 1, 1998
Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovirP V Balimane, I Tamai, A Guo, et al.
Clinical Pharmacology and Therapeutics|June 20, 2013
International Transporter Consortium commentary on clinically important transporter polymorphismsK M Giacomini, P V Balimane, S K Cho, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biopharmaceutics & Drug Disposition|May 30, 1998
Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in ratsP J Sinko, P V Balimane
Journal of Pharmacological and Toxicological Methods|March 29, 2001
Current methodologies used for evaluation of intestinal permeability and absorptionP V Balimane, S Chong, R A Morrison
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell lineA Guo, P Hu, P V Balimane, et al.
Biochemical and Biophysical Research Communications|October 1, 1998
Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovirP V Balimane, I Tamai, A Guo, et al.
Clinical Pharmacology and Therapeutics|June 20, 2013
International Transporter Consortium commentary on clinically important transporter polymorphismsK M Giacomini, P V Balimane, S K Cho, et al.
Pageof 1